Scarica l'app Stockscreener
0.2252
3.97%
-0.0093
Dopo l'orario di chiusura:
.23
0.0048
+2.13%
Precedente Chiudi:
$0.2345
Aprire:
$0.2275
Volume 24 ore:
397.65K
Relative Volume:
0.20
Capitalizzazione di mercato:
$7.46M
Reddito:
-
Utile/perdita netta:
$-22.71M
Rapporto P/E:
-0.0192
EPS:
-11.71
Flusso di cassa netto:
$-18.24M
1 W Prestazione:
+2.36%
1M Prestazione:
-18.67%
6M Prestazione:
-52.19%
1 anno Prestazione:
-73.51%
Intervallo 1D:
$0.217
$0.2335
Intervallo di 1 settimana:
$0.209
$0.2425
Portata 52W:
$0.2023
$3.97
Genprex Inc Stock (GNPX) Company Profile
Nome
Genprex Inc
Settore
Industria
Telefono
512-537-7997
Indirizzo
1601 TRINITY STREET, BLDG. B, AUSTIN, TX
Confronta GNPX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GNPX
Genprex Inc
|
0.2252 | 7.85M | 0 | -22.71M | -18.24M | -11.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Genprex Inc Stock (GNPX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-01-26 | Iniziato | National Securities | Buy |
| 2019-04-29 | Iniziato | Noble Capital Markets | Outperform |
Genprex Inc Borsa (GNPX) Ultime notizie
Beyond tomorrow, what are analysts' price targets for GNPX for the next quarter? - AInvest
News impact scoring models applied to Genprex Inc.Earnings Miss & AI Driven Stock Price Forecasts - Newser
Has Genprex Inc. formed a bullish divergence2025 Historical Comparison & Fast Gain Stock Trading Tips - Newser
Is Genprex Inc. stock bottoming outTrade Volume Summary & Reliable Price Breakout Alerts - Newser
Predicting Genprex Inc. trend using moving averagesMarket Performance Summary & Fast Exit and Entry Strategy Plans - Newser
Applying chart zones and confluence areas to Genprex Inc.Quarterly Earnings Report & Expert Curated Trade Ideas - Newser
Detecting support and resistance levels for Genprex Inc.July 2025 Gainers & Free Real-Time Volume Trigger Notifications - Newser
How to build a custom watchlist for Genprex Inc.July 2025 Levels & Precise Buy Zone Identification - Newser
Using fundamentals and technicals on Genprex Inc.Free Weekly Top Gainers Forecast Watchlist - Newser
Genprex GNPX 2025Q2 Earnings Preview Downside Ahead on Challenging Revenue Landscape - AInvest
What makes Genprex Inc. stock price move sharplyShort Term Gain Strategy with AI Logic - Newser
Multi factor analysis applied to Genprex Inc.Free High Win Rate Trading Opportunities - Newser
Technical analysis overview for Genprex Inc. stockFree Swing Trading Entry Point Signals - Newser
Is this a good reentry point in Genprex Inc.Free Capital Efficiency Optimized Stock Alerts - Newser
Quant Strategy Flags Genprex Inc. for EntryCommunity Shared Smart Money Signals Show Movement - beatles.ru
Is Genprex Inc. stock a top performer YTDBest Stocks for Rapid Income - thegnnews.com
Genprex GNPX 2025Q2 Earnings Preview Upside Ahead on Diabetes Gene Therapy Advancements - AInvest
Genprex Issues Stockholder Letter and Provides 2025 Corporate Update - The Malaysian Reserve
Genprex Issues Stockholder Letter And Provides 2025 Corporate Update - TradingView
Genprex Announces Stockholder Letter and Corporate Update - TipRanks
Genprex Achieves Major Clinical Milestones: CEO Reveals Ambitious Plans for Cancer and Diabetes Gene Therapies - Stock Titan
Genprex Inc. Rebounds From Oversold Zone — Now WhatPattern Alert With ROI Driven Strategy Shared - metal.it
How strong is Genprex Inc. company’s balance sheetOverwhelming profit margins - Jammu Links News
Is it the right time to buy Genprex Inc. stockBuild a winning investment strategy today - Jammu Links News
Should I hold or sell Genprex Inc. stock in 2025Discover high-impact investment opportunities - Jammu Links News
How many analysts rate Genprex Inc. as a “Buy”Get high-impact stock recommendations now - Jammu Links News
What catalysts could drive Genprex Inc. stock higher in 2025Free Stock Market Query - Jammu Links News
How volatile is Genprex Inc. stock compared to the marketBuild a portfolio for long-term financial success - Jammu Links News
Is Genprex Inc. stock overvalued or undervaluedExceptional risk-adjusted gains - Jammu Links News
What are the latest earnings results for Genprex Inc.Invest confidently with professional guidance - Jammu Links News
When is Genprex Inc. stock expected to show significant growthAchieve consistent high returns with low risk - Jammu Links News
What is the dividend policy of Genprex Inc. stockUnlock exclusive trading strategies for gains - Jammu Links News
What institutional investors are buying Genprex Inc. stockExpert guidance for superior capital growth - Jammu Links News
Is Genprex Inc. a growth stock or a value stockBuild a diversified portfolio for risk mitigation - Jammu Links News
Price action breakdown for Genprex Inc.Weekly Return Plan for Conservative Traders - Newser
Will Genprex Inc. stock benefit from interest rate changesFree Daily Volume Spike Trading Signals - Newser
Relative strength of Genprex Inc. in sector analysisROI Focused Watchlist with Trade Confidence - Newser
Genprex (GNPX) to Release Quarterly Earnings on Friday - Defense World
Genprex Inc Azioni (GNPX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):